Baxter/Genetics Institute recombinant Factor VIII
Executive Summary
Antihemophilic product has been in clinicals since March 1987. It was incorrectly reported in the Oct. 26 edition of "The Pink Sheet" (T&G-4) that the product had not yet entered clinical study.